Meijer Erik, Casanova Maria, Kim Hyewon, Llena-Nozal Ana, Lee Jinkook
University of Southern California, Los Angeles, USA.
California State University, Fullerton, USA.
Lancet Reg Health Eur. 2022 Jun 24;20:100445. doi: 10.1016/j.lanepe.2022.100445. eCollection 2022 Sep.
With population aging, the economic burden of dementia is growing in Europe. Understanding the economic costs of dementia provides an important basis for prioritization in public health policy and resource allocation.
We calculate the economic costs of dementia, including both direct medical and social care costs and indirect costs of informal care, for 11 countries in Europe. Costs are estimated using population-representative data from the Survey of Health, Ageing, and Retirement in Europe from 2004 to 2017, supplemented with external information about wages of care workers, dementia prevalence, and fraction of direct costs paid by other sources. We report overall costs for persons, both living and deceased with dementia and also isolate the costs attributable to dementia by estimating regression models that relate a given cost component to dementia while controlling for coexisting conditions and demographics. We make the monetary data comparable by adjusting for inflation and Purchasing Power Parity to 2018 euros.
Average annual direct out of pocket costs that can be attributed to dementia vary between EUR 253(95% CI: -17 to 522) and EUR 859 (95% CI: -587 to 2306) across countries, but are not statistically significant after adjustment for multiple testing. Average annual hours of informal care that can be attributed to dementia vary between 163 (95% CI: 27-299) and 1051 (95% CI: 15-2086) annual hours across countries, and are statistically significant in all countries before adjustment for multiple testing, and in seven out of 11 countries after this adjustment. Combining these estimates with external wage information in each country implies a burden between EUR 2687.4 (95% CI: 704.5 to 4670.3) and EUR 15,468 (95% CI: 8088.1 to 22,847.9) per individual with dementia per year depending on the country. When combined with external estimates of the fraction of direct costs covered by other payment sources (insurance, government) and numbers of individuals with dementia, estimates of the total costs of dementia at the country level vary from EUR 162.9 million (95% CI: 56.3 to 269.5) in Estonia to EUR 32,606.9 (95% CI: 13,893.9 to 51,319.9) in Germany. Informal care costs account for the largest proportion of costs attributable to dementia in all European countries, varying between about 50% and about 90%.
The economic burden of dementia on families in terms of direct out-of-pocket and informal care costs varies greatly by country, depending on the health and social care systems. Informal care costs accounts for the largest proportion of costs, requiring policy attention to dementia care provision and costs.
This project is funded by the National Institute on Aging, National Institutes of Health, USA (R01 AG030153).
随着人口老龄化,欧洲痴呆症的经济负担不断加重。了解痴呆症的经济成本为公共卫生政策的优先排序和资源分配提供了重要依据。
我们计算了欧洲11个国家痴呆症的经济成本,包括直接医疗和社会护理成本以及非正式护理的间接成本。成本估计使用了2004年至2017年欧洲健康、老龄化和退休调查中具有人口代表性的数据,并辅以有关护理人员工资、痴呆症患病率以及其他来源支付的直接成本比例的外部信息。我们报告了痴呆症患者(包括在世和已故)的总体成本,并通过估计回归模型来分离痴呆症导致的成本,该模型将给定的成本组成部分与痴呆症相关联,同时控制共存疾病和人口统计学因素。我们通过根据通货膨胀和购买力平价调整至2018年欧元,使货币数据具有可比性。
各国可归因于痴呆症的平均年度自付直接成本在253欧元(95%置信区间:-17至522欧元)至859欧元(95%置信区间:-587至2306欧元)之间,但在多重检验调整后无统计学意义。各国可归因于痴呆症的平均年度非正式护理时长在163小时(95%置信区间:27 - 299小时)至1051小时(95%置信区间:15 - 2086小时)之间,在多重检验调整前所有国家均具有统计学意义,调整后11个国家中有7个国家具有统计学意义。将这些估计值与每个国家的外部工资信息相结合,意味着每个痴呆症患者每年的负担在2687.4欧元(95%置信区间:704.5至4670.3欧元)至15468欧元(95%置信区间:8088.1至22847.9欧元)之间,具体取决于国家。当与其他支付来源(保险机构、政府)覆盖的直接成本比例的外部估计值以及痴呆症患者数量相结合时,国家层面痴呆症总成本的估计值从爱沙尼亚的1.629亿欧元(95%置信区间:5630万至2.695亿欧元)到德国的32.6069亿欧元(95%置信区间:13.8939亿至51.3199亿欧元)不等。在所有欧洲国家,非正式护理成本在可归因于痴呆症的成本中占比最大,在约50%至约90%之间。
痴呆症给家庭带来的经济负担,无论是直接自付成本还是非正式护理成本,因国家而异,这取决于卫生和社会护理系统。非正式护理成本占成本的比例最大,需要政策关注痴呆症护理的提供和成本。
本项目由美国国立卫生研究院国家老龄化研究所资助(R01 AG030153)。